Drug Development and Therapeutics

ORIGINAL ARTICLE
Year
: 2015  |  Volume : 6  |  Issue : 2  |  Page : 62--65

Spectrophotometric method for estimation of amiloride in bulk and tablet dosage form


Aitha Vijaya Lakshmi 
 Department of Chemistry, Sri Krishnadevaraya University, Kurnool, Andhra Pradesh, India

Correspondence Address:
Aitha Vijaya Lakshmi
Department of Chemistry, Sri Krishnadevaraya University, Kurnool, Andhra Pradesh
India

Abstract

Introduction: Amiloride chemically, 3,5-diamino-6-chloro-N-(diaminomethylene) pyrazine-2-carboxamide. It is used in the management of congestive heart failure, available as Amifru tab, Amimide. It causes adverse effects like Nausea, diarrhea and dizziness. Materials: 0.1 N Hydrochloric acid, 0.1 N Sodium hydroxide and 1 mg/ml amiloride drug solution were required. Spectral and absorbance measurements were made using ELICO UV-160 double beam Spectrophotometer. Method: Amiloride drug solution concentration range of 25 to 125ug/ml in 0.1N HCl medium was scanned over the wave length range of 235-320 against blank prepared in 0.1N NaOH solution. Two wavelengths are selected one at positive peak 245 nm and another at negative peak 290 nm, the amplitude is calculated from these values. Results and Discussion: The sum of the absolute values at these wavelengths is called amplitude. The amplitude is proportional to the amount of drug. High accuracy, reproducibility and low t-values were reported from the calibration curve plotted with the amplitude verses amount of drug. So the proposed method is simple, less time consuming and it can be successfully adopted for the estimation of amiloride.



How to cite this article:
Lakshmi AV. Spectrophotometric method for estimation of amiloride in bulk and tablet dosage form.Drug Dev Ther 2015;6:62-65


How to cite this URL:
Lakshmi AV. Spectrophotometric method for estimation of amiloride in bulk and tablet dosage form. Drug Dev Ther [serial online] 2015 [cited 2019 Jun 17 ];6:62-65
Available from: http://www.ddtjournal.org/text.asp?2015/6/2/62/162443


Full Text

 Introduction



Amiloride

AML is chemically, 3,5-diamino-6-chloro-N-(diaminomethylene) pyrazine-2-carboxamide. AML works by directly blocking the epithelial sodium channel there by inhibiting sodium reabsorption in the distal convoluted tubules and collecting ducts in the kidneys (this mechanism is the same for triamterene). This promotes the loss of sodium and water from the body, but without depleting potassium. The drug is often used in conjunction with thiazide (e.g., co-amilozide) or loop diuretics (e.g., co-amilofruse). Due to its potassium-sparing capacities, hyperkalemia (high blood potassium levels) are occasionally observed in patients taking AML. The risk is high in concurrent use of angiotensin converting enzyme inhibitors or spironolactonet. It is soluble in methanol. The structure of AML is as shown in [Figure 1].{Figure 1}

It is used in the management of hypertension and congestive heart failure. It is available in the market as a combination drug with furosemide such as amifru tablet, amimide and exna-k tablet. It is also available in combination with atenelol and hydrochlorothiazide namely Beta-Biduret cap, BP-loride tablet, hipres-D cap. It causes adverse effects such as nausea, diarrhea, dizziness, photosensitivity hypotension; bone marrow depression fatigue muscle cramps raised creatine phosphokinase level.

Only a few methods viz., high-performance liquid chromatography (HPLC), spectrofluorimetry, electrophoresis, ultraviolet (UV)-visible spectrophotometry appeared in the literature for the determination of AML in bulk and pharmaceutical formulations. [1],[2],[3],[4] There is a need for simple spectrophotometric method for the analysis of AML in pharmaceutical formulations. No spectrophotometric methods in UV regions are reported in the literature for AML analysis. In this paper, simple and sensitive UV spectrophotometric method for the analysis of AML was described. The method is based on the difference absorbance of AML in acid and base medium. No interference was observed in the analysis of AML from common excipients found in pharmaceutical formulation. The proposed method is economic when compared with HPLC methods.

 Materials and Methods



Instrumentation

After due calibration of the instrument, spectral and absorbance measurements are made using ELICO UV-160 a double beam spectrophotometer manufactured by M/S ELICO private Limited, Hyderabad, India. Pure AML sample was kindly gifted by BAL Pharma, Bangalore. All the chemicals used were of analytical grade. All the solutions were freshly prepared with double distilled water. Reagents were prepared afresh for every method.

Since the drug was stable in 0.1 M sodium hydroxide and 0.1 M hydrochloric acid, freshly prepared 0.1 M sodium hydroxide and 0.1 M hydrochloric acid were selected as the solvents for the developed method. [5],[6],[7]

Preparation of reagents

Hydrochloric acid (0.1 N)

Hydrochloric acid solution (0.1 N) is prepared by diluting the requisite volume of concentrated AR hydrochloric acid (Ranbaxy make) with distilled water and standardized by usual procedure.

NaOH solution (0.1 N)

It is prepared by dissolving 4 g of sodium hydroxide (Merck) to 1000 ml with distilled water.

Preparation of standard solution of drug

AML solution

AML 50 mg was weighed separately and dissolved in 0.1 M hydrochloric acid and 0.1 M sodium hydroxide separately. The solutions were made up to the volume 50 ml in volumetric flasks with 0.1 M hydrochloric acid and 0.1 M sodium hydroxide separately. 1 ml of this solution contains 1000 μg/ml. 2.5-12.5 ml of stock solutions were transferred into separate 100 ml volumetric flasks and diluted with 0.1 M hydrochloric acid and 0.1 M sodium hydroxide separately to get concentration ranging from 25 to 125 μg/ml.

Method

AML drug solutions ranging from 2.5 to 12.5 ml are taken in to a series of 100 ml standard flasks and to each flask 1 ml of 0.1 N hydrochloric acid is added. These flasks are scanned over the wave length range of 235-320 nm against reagent blank prepared by taking AML drug solution ranging from 2.5 to 12.5 ml in 100 ml volumetric flasks containing 1 ml of 0.1 M sodium hydroxide solution. From the absorbance values two wavelengths 245 and 290 nm are selected one at positive peak and another at negative peak, the amplitude is calculated from these values. [8],[9],[10],[11] The results are presented in [Figure 2].{Figure 2}

Calibration and amount of drug

The calibration curve is plotted between amplitude values and amount of drug (concentration of drug). The calibration curve is found to be linear over a concentration range of 25-125 μg/ml of AML. The amount of AML present in the sample is estimated from the calibration graph. The data and results are presented in [Table 1] and [Figure 3].{Figure 3}{Table 1}

Pharmaceutical analysis

Tablets powdered equivalent to 50 mg of the drug is weighed accurately and transferred into 50 ml standard flask and shaken well with 30 ml of methanol for 5 min. The solution is filtered into 50 ml standard flask and the volume is adjusted to 50 ml with methanol. One of the drug solutions is further diluted to 5 ml with distilled water to obtain the working concentration. The procedure described above is followed for the taken samples and the drug content is estimated from the calibration curve. The results are present in [Table 2].{Table 2}

Average ± standard deviation (SD) of six determinations, the t and F values refer to comparison of the proposed method with the reference method.

 Results and Discussion



The method is applied for the estimation of AML in pharmaceutical formulation. The drug solution in acid medium is scanned over the UV region by taking the basic drug solution as blank. From the absorbance values, spectrum is constructed. Two wave lengths are selected one at 245 nm and another at 290 nm. The sum of the absolute values at these wavelengths is called amplitude. The amplitude is proportional to the amount of drug. The calibration curve was plotted with the amplitude values verses amount of drug. The precession of the method was evaluated using the SD of the results and the coefficient of variation between the six values of the AML content in the tablets found by performing the assay of the powder blend in six replicates. The values of relative standard deviation (RSD) were found to be 0.145, 0.284 and 0.068, respectively. These low values of RSD indicate that the method is precise in estimating the content of AML from the tablet. The accuracy of the method to estimate the correct amount of the drug added was ascertained by using the t-test at each level. The t-values are found to be 0.184, 0.794 and 0.685 respectively. These values are lower than the " t" theoretical values with 4 ( n − 1 = 5 − 1) degrees of freedom at 5% level of significance indicates that there is no significant difference between proposed method and standard method. Thus, the method is accurate in estimating the AML content.

The proposed method is simple, less time consuming and it can be successfully adopted for the estimation of AML in tablets. Optical characteristics are presented in [Table 3].{Table 3}

 Conclusion



The SD, % of RSD and standard error calculated for the method are low and it indicates the high degree of precision of the method. The % RSD is also less than 2% as required by International Conference on Harmonization guidelines. The results of the recovery studies shows the high degree of accuracy of the proposed method. [12] Hence, the developed method is simple, rapid, precise, accurate, cost-effective and can be employed for the routine analysis of AML in both bulk and tablet dosage form.

Acknowledgments

The author is grateful to BAL Pharma Ltd., Bangalore, for providing pure drug samples, Department of Chemistry, S.K. University, Kurnool, Andhra Pradesh. for their continuous support and encouragement for providing the necessary infrastructure and facilities for executing this work.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1El-Gindy A, Emara S, Mostafa A. HPLC and chemometric-assisted spectrophotometric methods for simultaneous determination of atenolol, amiloride hydrochloride and chlorthalidone. Farmaco 2005;60:269-78.
2Erk N, Onuray F. Three new spectrophotometric methods for simultaneous determination of hydrochlorothiazide and amiloride hydrochloride in sugar-coated tablets. Anal Lett 1997;30:1503-15.
3Abdel-Hay MH, Gazy AA, Hassan EM, Belal TS. Derivative and derivative ratio spectrophotometric analysis of antihypertensive ternary mixture of amiloride hydrochloride, hydrochlorothiazide and timolol maleate. J Chin Chem Soc 2008;55:971-8.
4Lakshmi V. Spectrophotometric determination of amiloride in bulk and pharmaceutical formulations. Int J Pharm Pharm Sci 2013;5:298-302.
5Sweetman SC, editor. Martindale: The Complete Drug Reference. 35 th ed. London (UK): Pharmaceutical Press; 2007. p. 786.
6El-Sayed Y, Nizay EM, Khidr SH. High-performance liquid-chromatographic method for the quantitative determination of pheniramine in plasma. J Liq Chromatogr Relat Technol 1995;18:763-77.
7Ghanekar AG, Das Gupta V. Quantitative determination of four antihistamines in combination by high-pressure liquid chromatography. Am J Hosp Pharm 1977;34:651-3.
8Patel HN, Patel AV, Patel VJ, Dave JB, Patel CN. UV-spectrophotometric method for estimation of galantamine hydrobromide. J Chem Pharm Res 2010;2:44-9.
9Nanda RK, Gaikwad J, Prakash A. Simultaneous spectrophotometric estimation of cefixime and ornidazole. Int J Pharm Tech Res 2009;1:488-91.
10Gupta SC. Fundamentals of Statics. 4 th ed. New Delhi: Himalaya Publications House; 1999. p. 3-58.
11Sandell EB. Colorimetric Determination of Traces of Metals. New York: Inter Science; 1950. p. 29.
12Inczedy J, Lengyel T, Ure AM. IUPAC Compendium of Analytical Nomenclature: Definitive Rules. Boston, MA, USA: Blackwell Science; 1998.